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Current problems of experimental and clinical 
oncolo gy were discussed during the IX International 
Conference of Young Oncologists, which have been held 
in the R.E. Kavetsky Institute of Experimental Pathology, 
Oncology and Radiobiology (IEPOR), NAS of Ukraine. 
The meeting was dedicated to the 80th anniver-
sary of Zoya A. Butenko, academician of NASU, the 
first Ukrainian scientist who has started to study the 
molecular mechanisms of leukemogenesis and the 
role of stem cells in malignant transformation, as well 
as to the 85th anniversary of Dmytro G. Zatula, cor-
responding member of NASU, the author of original 
anticancer vaccine that has become a background for 
the development of cancer biotherapy which is actively 
elaborated in IEPOR nowadays. 
Our annual Conference of Young Oncologists has 
become now an international event. More and more 
young scientists working in the field of oncology attend 
this meeting. This year more than 150 scientists and 
physicians from different regions of Ukraine and CIS, 
in particular Belarus and Russia, have participated in 
the conference.
The program of the conference included the invited 
lectures which have been presented by the leading 
IEPOR scientists Prof. Danil Gluzman, Prof. Volodymyr 
Shliakhovenko, Prof. Ninel’ Berezhna and Dr. Grygoriy 
Potebnya.
The participants discussed actual scientific prob-
lems, such as molecular and genetic aspects of carci-
no- and leukemogenesis, the role of immune and other 
regulatory systems in the development of malignant 
tumors, the elaboration the nano- and biotechnologies 
to create effective means for tumor diagnostics and 
treatment of cancer patients. The best authors were 
awarded the special diplomas. 
The study of Natalia Val’kovs’ka (IEPOR, NASU) 
concerning the role of the ADAM8 protein in the de-
velopment of pancreas cancer was nominated as the 
best one among the works in experimental and clinical 
studies. The scientific committee also marked Anna 
Kudryavtseva study (Institute of Molecular Biology, 
RAS), concerning the changes in HYAL1 and HYAL2 
gene expression in malignant tumors of lung and kid-
ney. Some aspects of diagnostics in hematological 
diseases were presented by Tetiana Ivanivska (IEPOR, 
NASU). In the field of immunotherapy, the presentation 
of Olha Puzanova (N.N. Blokhin Institute of Experimen-
tal Diagnostics and Tumor Therapy, ROSC, RAMS) has 
been worthy of attention.
The scientific committee also nominated the best 
three posters devoted to the problems of molecular 
biolo gy and experimental immunotherapy. The poster 
presentation of Bohdan Bilyk (Institute of the Cell Bio-
logy, NASU) concerning the development of a new 
method to obtain overproducers of a human argi-
nase 1 by means of Hansenula polymorpha yeasts was 
awarded as the best. The second nomination was given 
to Volodymyr Sovenko (National Institute of Cancer of 
Ukraine), who reported his own experience in applying 
the dendritic cell autovaccines in the treatment of the 
patients with lung cancer staged as IIIA. The third award 
was given to Maryana Shabel’nyk (IEPOR, NASU) who 
had shown correlations between the number of prolifer-
ating cells and the level of their differentiation in tumor 
tissue of patients with gastric cancer with expression 
and autophosphorylation of PKD2.
Scientific committee also specially marked the 
work of Natalia Bezdenezhnykh (IEPOR, NASU). Her 
study deals with molecular-biological characteristics 
of the human lung cancer cells exposed to chemo-
therapy and hyperthermia in the setting of the long-
term interferon effects in vitro.
Discussing the results of the conference, academi-
cian of NASU Vasyl’ Chekhun has mentioned that such 
meeting is advantageous in summarizing the main 
achievements in immunology of tumor growth, which 
will be helpful in outlining new prospects for immuno-
diagnostics as well as cancer immunotherapy. Large 
attention was given to the possibility of elaborating new 
antitumor vaccines using dendritic cells or the products 
of microbial synthesis, an allogenic vaccine based on 
genetic engineering techniques. The efforts to enhance 
the activity of the lymphocytes as killer cells are also 
worthy of much attention. Several biotechnologies based 
on experimental studies are on their way to being imple-
mented in oncological practice. The results presented in 
the conference by young oncologists allow to hope for 
the development of new approaches for resolving the 
most difficult problems of modern oncology.
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